CTx Collaborates with Duke University for Cancer Drugs Discovery

Cancer Therapeutics CRC (CTx), Australia, has announced a collaboration with Duke University, North Carolina, US to discover and develop drugs for the treatment of cancer, based on research that is undertaken by the laboratory of Duke Professor Patrick Casey.

Professor Casey and his team have been investigating lipid signaling pathways and the role of lipid metabolising enzymes in cancer and have developed a series of inhibitors of these enzymes. CTx has taken an exclusive license to these inhibitors and will initiate a drug development program to bring these early stage compounds toward the clinic.